The Readout Loud Por: STAT STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. 386 episodios disponibles Latest episodes of the podcast The Readout Loud Mostrando página 8 de 20 244: Pharma blockbusters, pandemic policy, & legal chicanery 02/02/2023 243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection 26/01/2023 242: How blockbusters get made, new vaccines for RSV, and mRNA's Q score 19/01/2023 241: #JPM23 in review, the year ahead, & the merits of Miami 12/01/2023 240: #JPM23, the future of Alzheimer's, & rising Covid variants 05/01/2023 239: 2022 in review, CEO indictments, & the year ahead 22/12/2022 238: Leaky health data, ASH22, & what it takes to get booed by your peers 15/12/2022 237: The 'electric vehicles' of pharma, Illumina's boondoggle, & a Theranos sentencing 08/12/2022 236: Wither PhRMA, Alzheimer's treatment data revealed, and the first fecal microbiome drug approval 01/12/2022 235: LIVE from the STAT Summit 17/11/2022 234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy 10/11/2022 233: How the biotech revolution could come apart at the seams 03/11/2022 232: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms 27/10/2022 231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market 20/10/2022 230: BIO's messy transition, mRNA's future, & Biogen's next CEO 13/10/2022 229: Nobels for science, biotech dealmaking, & a friendly FTC 06/10/2022 228: A surprise success in Alzheimer's and how FDA history seeded modern controversy 29/09/2022 227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0 22/09/2022 226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred 15/09/2022 225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding 08/09/2022 « Primera ‹ Anterior 1 ... 6 7 8 9 10 ... 20 Siguiente › Última » Share Facebook Twitter LinkedIn